• December 8, 2024

Why Is Cogent Biosciences Stock Trading Higher On Monday?

On Sunday, Cogent Biosciences, Inc. (NASDAQ:COGT) revealed updated clinical results from the Open Label Extension (OLE) portion of the SUMMIT trial of bezuclastinib in patients with non-advanced systemic mastocytosis. Non-advanced systemic mastocytosis is a rare disease that involves mast cell buildup in tissues and organs. Updated clinical data presented at the American Society of Hematology Annual Meeting & Exposition show: 56% mean improvement in Total Symptom Score (TSS) at 24 weeks. 76% of

Read More

• December 8, 2024

Nvidia stock falls almost 3% as it faces an antitrust probe in China

Nvidia’s (NVDA) shares fell by almost 3% during mid-day trading on Monday after the Chinese government announced an investigation into the chipmaker. Fellow chipmakers Advanced Micro Devices (AMD) and Marvell (MRVL) also saw their shares fall by 4.4% and 5.2%, respectively.

Read More

• December 8, 2024

Omnicom to Purchase Interpublic Group in All-Stock Deal

Omnicom Group (OMC) agreed to acquire Interpublic Group of Cos. (IPG) in an all-stock deal to create

Read More

• December 8, 2024

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock

Jefferies has upgraded Kodiak Sciences Inc. (NASDAQ:KOD), a biopharmaceutical company focused on retinal (eye) diseases. Kodiak’s lead investigational medicine, tarcocimab, is an anti-VEGF antibody biopolymer conjugate under development for high-prevalence retinal vascular diseases. Tarcocimab is currently being studied in two Phase 3 trials, GLOW2 in diabetic retinopathy and DAYBREAK in patients with wet age-related macular degeneration (wet AMD). Both studies are actively enrolling patients. J

Read More

• December 8, 2024

Macy's Stock Rises as Activist Investors Call for Real Estate Unit

Barington Capital Group and Thor Equities called on Macy's to create a real estate subsidiary and limit its capital expenditures.

Read More

• December 8, 2024

‘The mother of all bubbles’ in the U.S. is sucking money away from the rest of the world, market expert says

“Awe of ‘American exceptionalism’ in markets has now gone too far,” said Ruchir Sharma, chair of Rockefeller International.

Read More

• December 8, 2024

Energy Transfer unveils $2.7bn pipeline linking Permian Basin to key markets

The first phase will connect the Energy Transfer pipeline and storage network, linking to the Dallas/Ft. Worth Metroplex.

Read More

• December 8, 2024

Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains

On Saturday, Beam Therapeutics Inc. (NASDAQ:BEAM) revealed new safety and efficacy data from its BEACON Phase 1/2 trial of BEAM-101 in patients with sickle cell disease (SCD) with severe vaso-occlusive crises (VOCs). The data were featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. Consistent with Beam’s previously announced data, updated data from seven patients treated with investigational base-editing therapy BEAM-101 demonstrated robust and durable increases i

Read More

• December 8, 2024

NYC ad agency titans Omnicom and Interpublic to form $30 billion marketing powerhouse

Omnicom is buying Interpublic Group in a stock-for-stock deal that will create the largest ad agency in the world with combined annual revenue of almost $26 billion. The names may be unfamiliar to many Americans, but some of their marketing campaigns are iconic. The combined company will be worth more than $30 billion.

Read More

• December 8, 2024

Tesla stock keeps soaring as Bank of America raises price target

Analysts have an unusual challenge in assessing how CEO Elon Musk’s relationship with President-elect Donald Trump will impact Tesla.

Read More